Approval · Notice of Compliance 6012 · 2004
KETEK: Notice of Compliance 6012
Issued December 22, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6012
- Date
- December 22, 2004
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: for treatment of acute sinusitis
- Therapeutic class
- Anti-bacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KETEK | Not yet assigned | — |
Medicinal ingredients
- TELITHROMYCIN 400 MG per TAB